1
|
Schmaier AH, Cicardi M, Reshef A, Moldovan D, Mócsai A, López-Trascasa M, Lera AL, Brown NJ, Germenis AE, Filippelli-Silva R, Duarte DA, Martin RP, Veronez CL, Bouvier M, Bader M, Costa-Neto CM, Pesquero JB, Charest-Morin X, Marceau F, Rivard GÉ, Bonnefoy A, Wagner É, Debreczeni ML, Németh Z, Kajdácsi E, Schwaner E, Cervenak L, Oroszlán G, Szilágyi A, Dani R, Závodszky P, Gál P, Dobó J, Hébert J, Vincent M, Boursiquot JN, Chapdeleine H, Desjardins M, Laramée B, Gagnon R, Payette N, Lepeshkina O, Charignon D, Ghannam A, Ponard D, Drouet C, Joseph K, Tholanikunnel BG, Sexton DJ, Kaplan AP, Loffredo S, Bova M, Ferrara AL, Petraroli A, Suffritti C, Veszeli N, Zanichelli A, Farkas H, Marone G, Luyasu S, Favier B, Martin L, Kőhalmi KV, Temesszentandrási G, Várnai K, Varga L, Zuraw BL, Feussner A, Tortorici MA, Pawaskar D, Li HH, Anderson J, Bernstein JA, Zhang Y, Pragst I, Aygören-Pürsün E, Jacobson K, Christensen J, Van Leerberghe A, Wang Y, Schranz J, Martinez-Saguer I, Soteres D, Steiner U, Panovska VG, Rae W, Aberer W, Huissoon A, Bygum A, Magerl M, Graff J, Longhurst H, Lleonart R, Fang L, Cornpropst M, Clemons D, Mathis A, Collis P, Dobo S, Sheridan WP, Maurer M, Riedl MA, Craig T, Banerji A, Shennak M, Yang W, Baptista J, Busse P, Kalfus I, McDonald A, Qian S, Roberts A, Panousis C, Green T, Gille A, Zamanakou M, Loules G, Csuka D, Psarros F, Parsopoulou F, Speletas M, Firinu D, De Pasquale TMA, Zoli A, Radice A, Pizzimenti S, Manoussakis E, Konstantinou GN, Bafunno V, Montinaro V, Cancian M, Margaglione M, Bork K, Wulff K, Witzke G, Hardt J, Bouillet L, Caballero T, Grumach AS, Pommie C, Andresen I, Ettingshausen CE, Gutowski Z, Andritschke K, Linde R, Andrási N, Szilágyi T, Leibovich-Nassi I, Symons C, Dempster J, Boccon-Gibod I, Pagnier A, Lehmann A, Kreiberg KB, Nieto SA, Martins R, Martins R, Menendez A, Valle SOR, Olivares M, Hernandez-Landeros ME, Nievas E, Fili N, Barrera OM, Bailleau R, Gallardo-Olivos AM, Grau M, Rodriguez-Galindo J, Carabantes MJO, Zapata-Venegas E, Alfonso MM, Rosario-Grauert M, Ratti M, Vaszquez D, Josviack D, Landivar-Salinas LF, Calderón-Llosa OME, Campilay-Sarmiento R, Raby P, Fabiani J, Lumry WR, Feuersenger H, Watson DJ, Machnig T, Lamacchia D, Hernanz A, Alvez A, Lluncor M, Pedrosa M, Cabañas R, Prior N, Nordenfelt P, Nilsson M, Lindfors A, Wahlgren CF, Björkander J, Hakl R, Kuklínek P, Krčmová I, Hanzlíková J, Vachová M, Zachová R, Sobotková M, Strenková J, Litzman J, Palasopoulou M, Tsinti G, Gianni P, Kompoti M, Garrido S, Dyga W, Bogdali A, Obtułowicz A, Tomasz M, Czarnobilska E, Obtulowicz K, Książek T, Koncz A, Gulyás D, Staevska M, Jesenak M, Hrubiskova K, Bellizzi L, Relan A, Wu MA, Castelli A, Colombo R, Podda G, Del Medico M, Catena E, Casella F, Perego F, Afifi NA, Tobaldini E, Montano N, Sánchez-Jareño M, Stobiecki M, Obtułowicz K, Guryanova I, Polyakova E, Lebedz V, Salivonchik A, Aleshkevich S, Belevtsev M, Nordmann-Kleiner M, Trainotti S, Hahn J, Greve J, Zabrodska L, Alonso MLO, Tórtora RP, França AT, Ribeiro MG, Fu L, Kanani A, Lacuesta G, Waserman S, Betschel S, Espinosa MI, Contreras FA, Hrubisko M, Vavrova L, Banovcin P, Ayazi M, Fazlollahi MR, Saghafi S, Mohammadian S, Deshiry SN, Bidad K, Shoormasti RS, Mohammadzadeh I, Bemanian MH, Mahdaviani SA, Pourpak Z, Valerieva A, Vasileva M, Velikova T, Petkova E, Dimitrov V, Di Maulo R, Somech R, Golander H, Sifuentes EJ, Mansard C, Gompel A, Floccard B, Blanchard-Delaunay C, Launay D, Fain O, Sobel A, Gayet S, Amarger S, Armengol G, Ollivier Y, Zélinsky-Gurung A, Jeandel PY, Kanny G, Coppéré B, Dubrel M, Pelletier F, Du Thanh A, Trouiller S, Laurent J, De Moreuil C, Pajot CA, Belot A, Rodríguez A, Roa D, Prieto A, Baeza ML, Krusheva B, Almeida SKA, Constantino-Silva RN, Melo N, Simoes JA, Palma SMU, da Silva J, de Azevedo BF, Mansour E, González-Quevedo T, Marcos C, Lobera T, de San Pedro BS, Avilla E, Badiou J, Binkley K, Borici-Mazi R, Howlett L, Keith PK, Rowe A, Waite P, Billebeau A, Boccon-Gibbod I, Lis K, Laitman Y, Friedman E, Gokmen NM, Gulbahar O, Onay H, Koc ZP, Sin AZ. Abstracts from the 10th C1-inhibitor deficiency workshop. Allergy Asthma Clin Immunol 2017. [PMCID: PMC5496025 DOI: 10.1186/s13223-017-0198-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
2
|
Dumortier J, Guillaud O, Bosch A, Coppéré B, Petiot P, Roggerone S, Vukusic S, Boillot O. Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome. Transpl Infect Dis 2016; 18:606-10. [DOI: 10.1111/tid.12554] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Revised: 03/14/2016] [Accepted: 03/17/2016] [Indexed: 12/31/2022]
Affiliation(s)
- J. Dumortier
- Fédération des Spécialités Digestives; Hospices civils de Lyon; Hôpital Edouard Herriot; Lyon France
- Université Claude Bernard Lyon 1; Lyon France
| | - O. Guillaud
- Fédération des Spécialités Digestives; Hospices civils de Lyon; Hôpital Edouard Herriot; Lyon France
| | - A. Bosch
- Fédération des Spécialités Digestives; Hospices civils de Lyon; Hôpital Edouard Herriot; Lyon France
- Université Claude Bernard Lyon 1; Lyon France
| | - B. Coppéré
- Service de Médecine Interne; Hospices civils de Lyon; Hôpital Edouard Herriot; Lyon France
| | - P. Petiot
- Service d'Explorations Fonctionnelles Neurologiques; Hospices civils de Lyon; Hôpital de la Croix-Rousse; Lyon France
| | - S. Roggerone
- Université Claude Bernard Lyon 1; Lyon France
- Service de Neurologie Unité 102; Hospices civils de Lyon; Hôpital Neurologique Pierre Wertheimer; Lyon France
| | - S. Vukusic
- Université Claude Bernard Lyon 1; Lyon France
- Service de Neurologie Unité 102; Hospices civils de Lyon; Hôpital Neurologique Pierre Wertheimer; Lyon France
| | - O. Boillot
- Fédération des Spécialités Digestives; Hospices civils de Lyon; Hôpital Edouard Herriot; Lyon France
- Université Claude Bernard Lyon 1; Lyon France
| |
Collapse
|
3
|
Durel CA, Aouba A, Bienvenu B, Deshayes S, Coppéré B, Gombert B, Acquaviva-Bourdain C, Hachulla E, Lecomte F, Touitou I, Ninet J, Philit JB, Messer L, Brouillard M, Girard-Madoux MH, Moutschen M, Raison-Peyron N, Hutin P, Duffau P, Trolliet P, Hatron PY, Heudier P, Cevallos R, Lequerré T, Brousse V, Lesire V, Audia S, Maucort-Boulch D, Cuisset L, Hot A. Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency. Medicine (Baltimore) 2016; 95:e3027. [PMID: 26986117 PMCID: PMC4839898 DOI: 10.1097/md.0000000000003027] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
The aim of this study was to describe the clinical and biological features of Mevalonate kinase deficiency (MKD) in patients diagnosed in adulthood. This is a French and Belgian observational retrospective study from 2000 to 2014. To constitute the cohort, we cross-check the genetic and biochemical databases. The clinical, enzymatic, and genetic data were gathered from medical records. Twenty-three patients were analyzed. The mean age at diagnosis was 40 years, with a mean age at onset of symptoms of 3 years. All symptomatic patients had fever. Febrile attacks were mostly associated with arthralgia (90.9%); lymphadenopathy, abdominal pain, and skin lesions (86.4%); pharyngitis (63.6%); cough (59.1%); diarrhea, and hepatosplenomegaly (50.0%). Seven patients had psychiatric symptoms (31.8%). One patient developed recurrent seizures. Three patients experienced renal involvement (13.6%). Two patients had angiomyolipoma (9.1%). All but one tested patients had elevated serum immunoglobulin (Ig) D level. Twenty-one patients had genetic diagnosis; most of them were compound heterozygote (76.2%). p.Val377Ile was the most prevalent mutation. Structural articular damages and systemic AA amyloidosis were the 2 most serious complications. More than 65% of patients displayed decrease in severity and frequency of attacks with increasing age, but only 35% achieved remission. MKD diagnosed in adulthood shared clinical and genetic features with classical pediatric disease. An elevated IgD concentration is a good marker for MKD in adults. Despite a decrease of severity and frequency of attacks with age, only one-third of patients achieved spontaneous remission.
Collapse
Affiliation(s)
- Cécile-Audrey Durel
- From the Internal Medicine Department, Edouard Herriot Hospital, Lyon (C-AD, BC, JN, M-HG-M, AH); Internal Medicine Department, Côte de Nacre Hospital, Caen (AA, BB, SD); Medicine and Rheumatology Department, Saint-Louis Hospital, La Rochelle (BG); Inborn Errors of Metabolism Laboratory, Civil Hospital of Lyon, Bron (CA-B); Internal Medicine Department, Claude Huriez Hospital, Lille (EH, P-YH); Polyvalent Medicine Department, Cornouaille Hospital Center, Quimper (FL, PH); Autoinflammatory Diseases Medical Unit, Arnaud Villeuneuve Hospital, Montpellier (IT); Nephrology Department, Metropole Savoie Hospital Center, Chambéry (J-BP); Rheumatology Department, Louis Pasteur Hospital, Colmar (LM); Hematology Department, Arras Hospital Center, Arras, France (MB); Internal Medicine Department, Sart Tilman, Liège, Belgique (MM); Dermatology and Allergology Department, Saint-Eloi Hospital, Montpellier (NR-P); Internal Medicine Department, Saint-André Hospital, Bordeaux (PD); Nephrology Department, Lyon Sud Hospital Center, Pierre-Bénite (PT); Hematology Department, Princesse Grace Hospital Center, Monaco (PH); Internal Medicine Department, Saint-Vincent Hospital Center, Strasbourg (RC); Rheumatology Department, Charles Nicole Hospital, Rouen (TL); Department of Pediatrics, Necker-Enfants Malades Hospital, Paris (VB); Diabetology and Internal Medicine Department, Blois Hospital Center, Blois (VL); Internal Medicine Department, Bocage Central, Dijon (SA); Service de Biostatistique, Hospices civiles de Lyon, Université de Lyon 1, Villeurbanne; CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne (DM-B); and Department of Biochemical Genetics, Hospital and Institut Cochin, Paris (LC), France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Vanhems P, Voirin N, Bénet T, Roche S, Escuret V, Régis C, Giard M, Lina B, Comte B, Coppéré B, Ecochard R. Detection of hospital outbreaks of influenza-like illness based on excess of incidence rates compared to the community. Am J Infect Control 2014; 42:1325-7. [PMID: 25444307 DOI: 10.1016/j.ajic.2014.08.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2014] [Revised: 08/14/2014] [Accepted: 08/14/2014] [Indexed: 10/24/2022]
Abstract
The risk of nosocomial influenza-like illness (noso-ILI) compared with that of community-acquired ILI was calculated during 3 influenza seasons (2004-2007) at a 1100-bed university hospital with a total of 21,519 hospitalized patients. Outbreaks of noso-ILI occurred in each season, although a protective effect against noso-ILI was also identified for other wards.
Collapse
|
5
|
Leroy C, Girard C, Girard-Madoux M, Coppéré B, Desmurs-Clavel H, Pérard L, Hot A, Ninet J. Une sarcoïdose qui en a dans le ventre. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
6
|
Joly P, Richard Colmant G, Varennes A, Francina A, Coppéré B, Delacour H. Massive haemolysis and methaemalbuminaemia in a patient with decompensated haemoglobin H disease. Br J Haematol 2013; 163:2. [DOI: 10.1111/bjh.12499] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Philippe Joly
- Laboratoire de Biochimie et Biologie moléculaire; Hôpital Edouard Herriot; Hospices Civils & Université Claude Bernard-Lyon 1; Lyon; France
| | - Gaëlle Richard Colmant
- Service de Médecine Interne; Hôpital Edouard Herriot; Hospices Civils & Université Claude Bernard-Lyon 1; Lyon; France
| | - Annie Varennes
- Laboratoire de Biochimie et Biologie moléculaire; Hôpital Edouard Herriot; Hospices Civils & Université Claude Bernard-Lyon 1; Lyon; France
| | - Alain Francina
- Laboratoire de Biochimie et Biologie moléculaire; Hôpital Edouard Herriot; Hospices Civils & Université Claude Bernard-Lyon 1; Lyon; France
| | - Brigitte Coppéré
- Service de Médecine Interne; Hôpital Edouard Herriot; Hospices Civils & Université Claude Bernard-Lyon 1; Lyon; France
| | - Hervé Delacour
- Laboratoire de Biochimie; Toxicologie et Pharmacologie cliniques; Hôpital d'instruction des armées Bégin; Service de Santé des Armées; Paris; France
| |
Collapse
|
7
|
Bénet T, Régis C, Voirin N, Robert O, Lina B, Cronenberger S, Comte B, Coppéré B, Vanhems P. Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis 2012; 12:30. [PMID: 22292886 PMCID: PMC3293022 DOI: 10.1186/1471-2334-12-30] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2011] [Accepted: 02/01/2012] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In acute-care hospitals, no evidence of a protective effect of healthcare worker (HCW) vaccination on hospital-acquired influenza (HAI) in patients has been documented. Our study objective was to ascertain the effectiveness of influenza vaccination of HCW on HAI among patients. METHODS A nested case-control investigation was implemented in a prospective surveillance study of influenza-like illness (ILI) in a tertiary acute-care university hospital. Cases were patients with virologically-confirmed influenza occurring ≥ 72 h after admission, and controls were patients with ILI presenting during hospitalisation with negative influenza results after nasal swab testing. Four controls per case, matched per influenza season (2004-05, 2005-06 and 2006-07), were randomly selected. Univariate and multivariate conditional logistic regression models were fitted to assess factors associated with HAI among patients. RESULTS In total, among 55 patients analysed, 11 (20%) had laboratory-confirmed HAI. The median HCW vaccination rate in the units was 36%. The median proportion of vaccinated HCW in these units was 11.5% for cases vs. 36.1% for the controls (P = 0.11); 2 (20%) cases and 21 (48%) controls were vaccinated against influenza in the current season (P = 0.16). The proportion of ≥ 35% vaccinated HCW in short-stay units appeared to protect against HAI among patients (odds ratio = 0.07; 95% confidence interval 0.005-0.98), independently of patient age, influenza season and potential influenza source in the units. CONCLUSIONS Our observational study indicates a shielding effect of more than 35% of vaccinated HCW on HAI among patients in acute-care units. Investigations, such as controlled clinical trials, are needed to validate the benefits of HCW vaccination on HAI incidence in patients.
Collapse
Affiliation(s)
- Thomas Bénet
- Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'Hygiène, Epidémiologie et Prévention, Lyon, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Amour S, Voirin N, Regis C, Bouscambert-Duchamp M, Comte B, Coppéré B, Pires-Cronenberger S, Lina B, Vanhems P. Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004–2009). Vaccine 2012; 30:821-4. [DOI: 10.1016/j.vaccine.2011.11.033] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2011] [Revised: 11/06/2011] [Accepted: 11/09/2011] [Indexed: 10/14/2022]
|
9
|
Guichon C, Floccard B, Coppéré B, Hautin E, Bagès-Limoges F, Rouvière O, Monnier N, Drouet C, Allaouchiche B. One hypovolaemic shock…two kinin pathway abnormalities. Intensive Care Med 2011; 37:1227-8. [PMID: 21484080 DOI: 10.1007/s00134-011-2225-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/22/2011] [Indexed: 11/28/2022]
|
10
|
Saadoun D, Resche-Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppéré B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P. Systemic Diseases. Clin J Am Soc Nephrol 2010. [DOI: 10.2215/01.cjn.0000927128.76023.f1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
|
11
|
Grünfeld JP, Stangou AJ, Fernandez-Nebro A, Kastritis E, Saadoun D, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, Monaghan M, MacCarthy P, Buxton-Thomas M, Mathias CJ, Liepnieks JJ, O'Grady J, Heaton ND, Benson MD, Olivé A, Castro MC, Varela AH, Riera E, Irigoyen MV, Jesús M, de Yébenes G, Garcia-Vicuna R, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins P, Perfetti V, Gillmore JD, Palladini G, Resche-Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppéré B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P. Systemic Diseases: From Amyloidosis to CryoglobulinemiaHereditary fibrinogen A α-chain amyloidosis: Phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 115: 2998–3007, 2010Long-term TNF-α blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. Am J Med 123: 454–461, 2010Bortezomib with or without dexamethasone in primary systemic (light-chain) amyloidosis. J Clin Oncol 28: 1031–1037, 2010Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 116: 326–334, 2010. Clin J Am Soc Nephrol 2010; 5:1912-5. [DOI: 10.2215/cjn.08130910] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
12
|
Hot A, Toh ML, Coppéré B, Perard L, Girard Madoux MH, Mausservey C, Desmurs-Clavel H, Ffrench M, Ninet J. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore) 2010; 89:37-46. [PMID: 20075703 DOI: 10.1097/md.0b013e3181caf100] [Citation(s) in RCA: 79] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
Reactive hemophagocytic syndrome (RHS) is a rare, life-threatening, and little-known complication of rheumatic diseases. This disorder is characterized by fever, pancytopenia, liver failure, coagulopathy, and neurologic symptoms. RHS may develop in patents who have lymphoma, organ transplantation, serious infection, and rheumatic diseases, most notably systemic lupus erythematosus and adult-onset Still disease (AOSD). Observations of specific cases of RHS in AOSD remain rare, and the significance of this syndrome during the course of AOSD remains unknown. We retrospectively studied 16 episodes of AOSD-associated RHS in 8 patients. To determine whether RHS is associated with a particular phenotype of AOSD, we conducted a case-control study from the cohort of AOSD patients seen during the same period. The estimated frequency of RHS in AOSD patients from our cohort was 15.3% (8/52). The median age at RHS diagnosis was 44.5 years. We collected clinical and laboratory data. RHS was the first manifestation of AOSD in 7 cases. The main symptoms were fever (n = 8), salmon rash (n = 6), arthralgia (n = 7), lymphadenopathy (n = 6), and shock (n = 4). Serum ferritin concentration was consistently elevated (>1000 microg/L in 8 cases), and the level of glycosylated ferritin was low in all cases (<5% in 7 cases, 15% in 1 case). Six patients presented with coagulopathy; hypertriglyceridemia was found in 6 cases. Admission to the intensive care unit was required in 4 cases. Treatment included corticosteroids (n = 8) and intravenous immunoglobulin (n = 6), cyclophosphamide in 2 cases, infliximab in the same 2 cases, and cyclosporine in 1 case. With a follow-up ranging from 2 to 15 years, the patients were in remission with prednisone plus methotrexate (n = 4), prednisone plus infliximab (n = 2), and low-dose prednisone alone (n = 2). We compared the 8 patients included in this study with 44 control patients with AOSD without RHS. Low haptoglobin levels, very high ferritin levels (>10,000 microg/L), and a normal or low neutrophil count seem to be predictive factors of the occurrence of RHS in AOSD.
Collapse
Affiliation(s)
- Arnaud Hot
- From Service de Médecine Interne (AH, BC, LP, MHGM, CM, HDC, JN); and Unité Mixte Inflammation et Immunité (AH, MLT), HCL-Biomérieux; Hôpital Edouard Herriot, Lyon; Université Claude Bernard Lyon I (AH, CM, JN), Lyon; and Service de Cytologie et Histopathologie Médullaire (MF), Centre Hospitalier Lyon SUD, Pierre Bénite, France
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Sabouraud S, Coppéré B, Rousseau C, Testud F, Pulce C, Tholly F, Blanc M, Culoma F, Facchin A, Ninet J, Chambon P, Medina B, Descotes J. Intoxication environnementale par le plomb liée à la consommation de boisson conservée dans une cruche artisanale en céramique vernissée. Rev Med Interne 2009; 30:1038-43. [DOI: 10.1016/j.revmed.2008.05.010] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2007] [Revised: 04/24/2008] [Accepted: 05/08/2008] [Indexed: 11/25/2022]
|
14
|
Terrier B, Saadoun D, Sène D, Sellam J, Pérard L, Coppéré B, Karras A, Blanc F, Buchler M, Plaisier E, Ghillani P, Rosenzwajg M, Cacoub P. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients. ACTA ACUST UNITED AC 2009; 60:2531-40. [PMID: 19644879 DOI: 10.1002/art.24703] [Citation(s) in RCA: 88] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
OBJECTIVE To report on the long-term followup of a cohort of patients with hepatitis C virus (HCV)-related vasculitis treated with rituximab with or without PEGylated interferon alfa-2b (PEG-IFN alfa-2b) plus ribavirin. METHODS The study group comprised 32 HCV RNA-positive patients with HCV-related vasculitis: 20 patients were treated with rituximab and PEG-IFN alfa-2b (9 of whom had not previously received antiviral treatment and 11 of whom had experienced disease resistance to or relapse with antiviral treatment), and 12 antiviral-intolerant patients were treated with rituximab alone. RESULTS Treatment with rituximab and PEG-IFN alfa-2b plus ribavirin induced a complete clinical response and a partial clinical response in 80% and 15% of patients, respectively, a complete immunologic response and a partial immunologic response in 67% and 33% of patients, respectively, and a sustained virologic response in 55% of patients. Treatment with rituximab alone induced a complete clinical response and a partial clinical response in 58% and 9% of patients, respectively, and a complete immunologic response and a partial immunologic response in 46% and 36% of patients, respectively. B cell depletion was achieved in 96% of patients, and B cell recovery began after a median delay of 12 months. After a mean+/-SD followup period of 23+/-12 months, 22% of patients experienced a clinical relapse, and 34% of patients experienced an immunologic relapse. All relapses were associated with the absence of virologic control, and 78% of relapses were associated with B cell recovery. Six patients were re-treated with rituximab. All 6 of these patients had a complete clinical response, 50% had a complete immunologic response, and 50% had a partial immunologic response. Rituximab was well tolerated overall. CONCLUSION Rituximab is an effective treatment of severe and/or refractory HCV-related vasculitis. Relapses were consistently associated with the absence of virologic control. The clinical and immunologic efficacy of rituximab after repeated infusion appeared to be the same as that observed after induction therapy.
Collapse
Affiliation(s)
- Benjamin Terrier
- Department of Internal Medicine, Groupe Hospitalier Pitié-Salpétrière, Assistance Publique-Hôpitaux de Paris (AP-HP), CNRS UMR 7211, and Université Pierre et Marie Curie Paris 6, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Gaultier JB, Hot A, Mauservey C, Dumortier J, Coppéré B, Ninet J. Granulomatose hépatique révélatrice d’une échinococcose alvéolaire chez un adulte transplanté cardiaque, infecté par le virus de l’hépatite C. Rev Med Interne 2009; 30:812-5. [DOI: 10.1016/j.revmed.2008.11.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2007] [Revised: 11/10/2008] [Accepted: 11/29/2008] [Indexed: 10/21/2022]
|
16
|
Hot A, Madoux MHG, Viard JP, Coppéré B, Ninet J. Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins. Am J Hematol 2008; 83:159-62. [PMID: 17849465 DOI: 10.1002/ajh.21008] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Virus-associated hemophagocytic syndrome (VAHS) is a rare complication in early cytomegalovirus (CMV) infection. There is no standard therapy for VAHS and the clinical course is variable. Data on the use of intravenous immunoglobulin (IVIG) in the treatment of CMV-associated VAHS are limited. We report a previously healthy, 32-year-old woman who presented with general malaise, fever, chills, and splenomegaly. Laboratory examination showed marked elevation of aminotransferase, leucopoenia, and thrombocytopenia. Acute CMV-infection was documented by the presence of immunoglobulin M anti-CMV and positive viremia in blood sample. Bone marrow examination revealed extensive hemophagocytosis. IVIG was administered after the diagnosis of CMV-associated VAHS. Her symptoms and laboratory abnormalities improved dramatically after the onset of the treatment and she did not require antiviral agent.
Collapse
Affiliation(s)
- Arnaud Hot
- Service de Médecine interne, Hôpital Edouard Herriot, Université Claude Bernard, Lyon, France.
| | | | | | | | | |
Collapse
|
17
|
Pérard L, Hot A, Cucherat M, Simon M, Desmurs H, Coppéré B, Girard-Madoux MH, Boissel JP, Ninet J. [Non-inferiority trial used in venous thromboembolic disease. A warily interpretation is necessary!]. Rev Med Interne 2007; 28:731-6. [PMID: 17597259 DOI: 10.1016/j.revmed.2007.05.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2006] [Accepted: 05/04/2007] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Equivalence trials are actually frequently used to prove non-inferiority in anticoagulant therapy. Equivalence trials consist to demonstrate that two treatments are not too much different. This difference has to be under a margin previously determined. The margin corresponds to an efficacy loss that is defined to be acceptable, in accordance to the advantages due to the new treatment. The aim of this work is to explore the equivalence trial published in the thromboembolic disease by focus on the non-inferiority margin used. METHODS We identified published equivalence trials in the venous thromboembolic disease, by a systematic search in Medline. We calculated the efficacy loss by reference with the value of the smallest effect size of the standard treatment compared to placebo. RESULTS We found 9 equivalence trials used in venous thromboembolic disease. The mean value of the efficacy loss was 434%, and the median value was 357%. Eighty-five percent of the values of the efficacy loss were above 100%. DISCUSSION Eighty-five percent of the equivalence trials conclude to equivalence despite a complete efficacy loss of the effect of the standard treatment compared to placebo. The results of equivalence trials should be interpreted warily. The corresponding non-inferiority margin should be chosen more rigorously and by reference with the value of the smallest effect size of the standard treatment compared to placebo.
Collapse
Affiliation(s)
- L Pérard
- Service de médecine interne, hôpital Edouard-Herriot, place d'Arsonval, 69008 Lyon, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Pérard L, Desmurs H, Hot A, Simon M, Streichenberger N, Coppéré B, Ninet J, Girard Madoux M. Une lipidose musculaire par déficit en Acyl CoA déshydrogénase révéler par une hypokaliémie sévère. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
19
|
Hot A, Pérard L, Coppéré B, Dupond JL, Lorcerie B, Seve P, Catebras P, Vital Durand D, Ninet J, Rousset H. Devenir à cinq ans des malades dont la fièvre prolongée reste inexpliquée au-delà d'un an. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Hot A, Pérard L, Hervieu V, Coppéré B, Desmurs-Clavel H, Rousset H, Durand DV, Ninet J. Apport de la biopsie hépatique au diagnostic des fièvres prolongées inexpliquées. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.308] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
21
|
Pérard L, Hot A, Desmurs H, Simon M, Clerici G, Maignan M, Coppéré B, Girard Madoux MH, Finet G, Ninet J. Thrombose coronaire survenue sous AVK chez un patient porteur d'un déficit hétérozygote du facteur V Leiden. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
22
|
Hot A, Coppéré B, Pérard L, French M, Rousset H, Vital Durand D, Madoux MHG, Ninet J. Contribution de la biopsie ostéomédullaire au diagnostic des syndromes inflammatoires biologiques chroniques. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
23
|
Desmurs-Clavel H, Pérard L, Gaillard S, Simon M, Hot A, Vial T, Montcharmont P, Girard Madoux MH, Coppéré B, Ninet J. Microangiopathie thrombotique réfractaire traitée par rituximab et aggravation brutale de la thrombopénie: imputabilité du rituximab? Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
24
|
Hot A, Pérard L, Coppéré B, Rousset H, Durand DV, Madoux MHG, Desmurs-Clavel H, Ninet J. Diagnostic étiologique des fièvres récurrentes à l'age adulte: a propos de 95 observations. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
25
|
Chanderis MO, Hot A, Loulergue P, Coppéré B, Charles P, Ninet J, Lortholary O. Aspects iconographiques des syndromes de reconstitution immunitaire chez les patients séronégatifs pour le VIH présentant une tuberculose ganglionnaire. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
26
|
Dargaud Y, Cruchaudet BB, Lienhart A, Coppéré B, Ninet J, Négrier C. Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagul Fibrinolysis 2003; 14:407-9. [PMID: 12945884 DOI: 10.1097/00001721-200306000-00013] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Venous thrombosis is a very rare occurrence in patients with haemophilia A. The majority of these cases occurred during or after the administration of clotting factor concentrates. We report the case of a patient with severe haemophilia A, who spontaneously developed a deep venous thrombosis (DVT). The thrombosis occurred in the superficial femoral vein with an extension in the profunda femoris vein. Neither any local anatomic compression nor any predisposing thrombophilic risk factors were identified. Treatment with recombinant factor VIII at prophylactic doses associated with unfractionated heparin led to a successful resolution. This case illustrates the possibility for severe haemophilia patients to develop authentic spontaneous DVT without anti-haemophilic treatment and predisposing risk factors.
Collapse
Affiliation(s)
- Yesim Dargaud
- Centre Regional de Traitement de l'Hémophilie, Pavilion E, Hôpital Edouard Herriot, Lyon, France
| | | | | | | | | | | |
Collapse
|
27
|
Roux M, Coppéré B, Desmurs H, Ninet J. [Septic arthritis caused by Aeromonas hydrophila]. Presse Med 2000; 29:839. [PMID: 10827789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
|
28
|
Desmurs H, Coppéré B, Stouls T, Girard-Madoux MH, Ninet J. Un diagnostic « au bout des lèvres. Rev Med Interne 1998. [DOI: 10.1016/s0248-8663(98)80164-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Saad A, Coppéré B, Matas O, Desmurs H, Girard-Madoux MH, Marcellin X, Stouls T, Dolmazon C, Ducluzeau R, Ninet J. Les paraplégies et tétraplégies aiguës non traumatiques observées en urgence médicale : à propos d'une série rétrospective de 30 cas. Rev Med Interne 1998. [DOI: 10.1016/s0248-8663(98)90053-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
30
|
Leman S, Ninet J, Coppéré B, Ducluzeau R, Stouls T, Matas O, Adeleine P. Les accidents vasculaires cérébraux du sujet jeune: étiologies et évolution (à propos d’une série rétrospective de 134 cas). Rev Med Interne 1997. [DOI: 10.1016/s0248-8663(97)80205-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Chaumentin G, Stouls T, Coppéré B, Miranda P, Madoux MHG, Ninet J. Un ictère fébrile. Rev Med Interne 1996. [DOI: 10.1016/0248-8663(96)86469-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
32
|
Bréchignac X, Pinède L, Laplace S, Coppéré B, Rague SD, Duhaut P, Ninet J, Pasquier J. [Acute pancreatitis, an unknown complication of acute intravascular hemolysis]. Rev Med Interne 1996; 17:172-3. [PMID: 8787093 DOI: 10.1016/0248-8663(96)82971-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
|
33
|
Coppéré B, Dupin A, Vial T, Matas O, Piqueras E, Richalet C, Sarrot-Raynaud F, Pinède L, Rousset H, Ninet J. Accidents artériels ischémiques aigus associés à la bromocriptine à propos de six cas observés en post-partum. Rev Med Interne 1996. [DOI: 10.1016/s0248-8663(97)80957-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Grasser L, Ninet J, Trzeciak M, Amaranto P, Girard-Madoux M, Coppéré B, Pasquier J. Symptômes et évolution de 157 patients porteurs d'anticorps antiphospholipides: étude rétrospective. Rev Med Interne 1996. [DOI: 10.1016/s0248-8663(97)80914-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
35
|
Bréchignac X, Coppéré B, Pinède L, Ninet J, Demolombe Rague S, Duhaut P, Pasquier J. [Capillary hyperpermeability syndrome: a new case]. Rev Med Interne 1995; 16:227-8. [PMID: 7740237 DOI: 10.1016/0248-8663(96)80698-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
36
|
Girard-Madoux MH, Pinede L, Ninet J, Berger F, Coppéré B, Pasquier J. [Wegener's granulomatosis, with successive lung and orbit involvement, occurring 14 and 4 years before systemic symptoms as well as renal and sinusal sites]. Ann Med Interne (Paris) 1995; 146:598-600. [PMID: 8734093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
37
|
Claudel JP, Ninet J, Coppéré B. [Cholesterol embolism in the lower limbs]. Rev Prat 1995; 45:56-61. [PMID: 7725010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
An atheromatous aorta may be the source of micro-emboli composed of cholesterol crystals. These cholesterol emboli presumably result from dislodgment of atheromatous material occurring either spontaneously, or consecutively to a coronary angiography, an aortic surgery or even an anticoagulant or thrombolytic treatment. Even if the best known clinical feature is the "blue toe" syndrome together with renal insufficiency, the spectrum of disease caused by cholesterol emboli ranges from asymptomatic to rapidly progressive multiple system failure. Therefore cholesterol embolism is a serious complication of aortic atherosclerosis and often holds a poor prognosis. Diagnosis is confirmed by skin or muscle biopsy and fundoscopic examination. The optimal treatment remains to be established.
Collapse
Affiliation(s)
- J P Claudel
- Service de soins intensifs cardiologiques, Hôpital cardiologique Louis-Pradel, Lyon
| | | | | |
Collapse
|
38
|
Coppard MP, Ninet J, Duhaut P, Boussuge C, Berger F, Girard-Madoux MH, Demolombe-Ragué S, Coppéré B, Pinède L, Pasquier J. Maladie de Horton et pseudopolyarthrite rhizomélique. Comparaison historique de deux séries d'un même service. À propos de 177 cas. Rev Med Interne 1994. [DOI: 10.1016/s0248-8663(05)82625-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
39
|
Brechignac X, Coppéré B, Pinède L, Ninet J, Demolombe-Rague S, Duhaut P, Pasquier J. Syndrome d'hyperperméabilité capillaire. À propos d'une observation. Rev Med Interne 1994. [DOI: 10.1016/s0248-8663(05)82664-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Salles G, Vignal M, Ninet J, Berger F, Coiffier B, Girard-Madoux MH, Coppéré B, Ravault M, Pasquier J. [Clinical study of 12 cases of malignant non-Hodgkin's lymphoma of the orbital region]. Ann Med Interne (Paris) 1993; 144:168-172. [PMID: 8368700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Over an 8-year period in the Departments of Hematology, Ophthalmology and Internal Medicine of our hospital, 12 cases of orbital and adnexal malignant non-Hodgkin's lymphoma were reported. Diagnostic elements varied, including local tumefaction, watering eyes, uveitis, and unexplained, long-term fever. Nine patients had primary paraocular lymphomas involving either orbital structures, the lacrimal gland or the eyeball, but after appropriate staging, the disease was found to be disseminated in 5; the 3 other cases were secondary orbital lymphomas. Intermediate or high grade histological types were predominant (9 patients) in our series. Radiation therapy, alone or combined (5 patients) with chemotherapy, was administered in 8 cases; other treatments consisted of chemotherapy (2 cases) or steroids (2 cases). Evolution was poor, with only 4 patients surviving at 34-180 months of follow-up. The main prognostic factors were tumor stage and histological grade. The clinical characteristics of this group are compared to those reported in the literature.
Collapse
Affiliation(s)
- G Salles
- Service d'Hématologie, Hôpital Edouard-Herriot, Lyon
| | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Claudel J, Cahen R, Levrat R, Ninet J, Vital Durand D, Coppéré B, Pasquier J, François B, Delahaye J. Facteurs déclenchants des embolies de cristaux de cholestérol. Analyse de 26 observations. Rev Med Interne 1992. [DOI: 10.1016/s0248-8663(05)81596-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|